MedTrace Logo

Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis

NCT05731778 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2023-02-16

No results posted yet for this study

Summary

Evaluate a stannous technology for its effect on the neutrophil phenotype during an induced gingivitis state.

Conditions

  • Gingivitis

Interventions

DRUG

Stannous Fluoride Toothpaste

0.454% stannous fluoride toothpaste

DRUG

Colgate fluoride toothpaste

0.76 % Sodium MonoFluorophosphate (MFP)

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Principal Investigators

  • Michael Glogauer, DDS/PhD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-22
Primary Completion
2020-12-22
Completion
2020-12-22

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05731778 on ClinicalTrials.gov